The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
locations
companies founded by graduates and faculty in the last 10 years
of the student body are Arab Israeli
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs Seen in Times of Israel
Israeli researchers have developed an innovative method that enables medicine to be manufactured within the body itself.
The pioneering approach, not yet tested on humans, uses live, harmless bacteria that act like tiny factories, producing therapeutic proteins inside the body, exactly where they are needed.
“We are accustomed to thinking that to introduce a drug into the body, it must be manufactured in a factory and then delivered via a capsule or an injection,” said Prof. Boaz Mizrahi of the Technion – Israel Institute of Technology’s lab for biomaterials in the Faculty of Biotechnology and Food Engineering.
“This could be a turning point in the world of pharmaceuticals, and a new paradigm for both drug production and consumption,” he added.
Mizrahi recently spoke with The Times of Israel in a joint interview with Dr. Adi Gross, the study’s lead researcher.
by
www.timesofisrael.com (opens in a new tab)
on
January 09, 2026
Find out how therapeutic proteins can be manufactured where needed in the body, thanks to innovative research from Israeli scientists.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Intelligent Drugs / Biotech / Nanotechnology / Natural Sciences /
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can. Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.